BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21561740)

  • 1. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.
    Stroup TS; Appelbaum PS; Gu H; Hays S; Swartz MS; Keefe RS; Kim SY; Manschreck TC; Boshes RA; McEvoy JP; Lieberman JA
    Schizophr Res; 2011 Aug; 130(1-3):47-52. PubMed ID: 21561740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
    Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
    Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study.
    Wang X; Yu X; Appelbaum PS; Tang H; Yao G; Si T; Ma Y; Li T; Yu L; Shi C; Ma Y; Li L
    Schizophr Res; 2016 Jan; 170(1):162-7. PubMed ID: 26678983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Wu BJ; Liao HY; Chen HK; Lan TH
    Psychiatry Res; 2016 Mar; 237():323-30. PubMed ID: 26847945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia.
    Dunn LB; Palmer BW; Appelbaum PS; Saks ER; Aarons GA; Jeste DV
    Schizophr Res; 2007 Jan; 89(1-3):110-8. PubMed ID: 17020803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent in medication-free schizophrenia research.
    Moser DJ; Reese RL; Schultz SK; Benjamin ML; Arndt S; Fleming FW; Andreasen NC
    Am J Psychiatry; 2005 Jun; 162(6):1209-11. PubMed ID: 15930073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity of forensic patients to consent to research: the use of the MacCAT-CR.
    McDermott BE; Gerbasi JB; Quanbeck C; Scott CL
    J Am Acad Psychiatry Law; 2005; 33(3):299-307. PubMed ID: 16186191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity to provide informed consent among adults with bipolar disorder.
    Klein CC; Jolson MB; Lazarus M; Masterson B; Blom TJ; Adler CM; DelBello MP; Strakowski SM
    J Affect Disord; 2019 Jan; 242():1-4. PubMed ID: 30153563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.
    Dunn LB; Palmer BW; Keehan M; Jeste DV; Appelbaum PS
    Am J Psychiatry; 2006 Mar; 163(3):500-6. PubMed ID: 16513873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.
    Candilis PJ; Fletcher KE; Geppert CM; Lidz CW; Appelbaum PS
    Schizophr Res; 2008 Feb; 99(1-3):350-8. PubMed ID: 18164593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the capacity of inpatients with chronic schizophrenia to provide informed consent for participation in clinical trials; use of the Hebrew version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR).
    Linder M; Lev-Ari L; Kurs R; Melamed Y
    Isr Med Assoc J; 2012 Aug; 14(8):470-4. PubMed ID: 22977964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competence to consent and insight in schizophrenia: is there an association? A pilot study.
    Capdevielle D; Raffard S; Bayard S; Garcia F; Baciu O; Bouzigues I; Boulenger JP
    Schizophr Res; 2009 Mar; 108(1-3):272-9. PubMed ID: 19162443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
    Kim SY; Appelbaum PS; Swan J; Stroup TS; McEvoy JP; Goff DC; Jeste DV; Lamberti JS; Leibovici A; Caine ED
    Br J Psychiatry; 2007 Jul; 191():38-43. PubMed ID: 17602123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.
    Jeste DV; Palmer BW; Golshan S; Eyler LT; Dunn LB; Meeks T; Glorioso D; Fellows I; Kraemer H; Appelbaum PS
    Schizophr Bull; 2009 Jul; 35(4):719-29. PubMed ID: 18245061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the French Version of the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) in a French Sample of Individuals with Schizophrenia: Validation de la version française de l'instrument d'évaluation des compétences MacArthur-traitement (MacCAT-T) dans un échantillon français de personnes souffrant de schizophrénie.
    Raffard S; Lebrun C; Laraki Y; Capdevielle D
    Can J Psychiatry; 2021 Apr; 66(4):395-405. PubMed ID: 33064578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mental capacity, treatment as usual and time: magnitude of change in secure hospital patients with major mental illness.
    Dornan J; Kennedy M; Garland J; Rutledge E; Kennedy HG
    BMC Res Notes; 2015 Oct; 8():566. PubMed ID: 26467781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competence to consent to research among long-stay inpatients with chronic schizophrenia.
    Kovnick JA; Appelbaum PS; Hoge SK; Leadbetter RA
    Psychiatr Serv; 2003 Sep; 54(9):1247-52. PubMed ID: 12954941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive insight as an indicator of competence to consent to treatment in schizophrenia.
    Raffard S; Fond G; Brittner M; Bortolon C; Macgregor A; Boulenger JP; Gely-Nargeot MC; Capdevielle D
    Schizophr Res; 2013 Mar; 144(1-3):118-21. PubMed ID: 23313358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity to provide informed consent for participation in schizophrenia and HIV research.
    Moser DJ; Schultz SK; Arndt S; Benjamin ML; Fleming FW; Brems CS; Paulsen JS; Appelbaum PS; Andreasen NC
    Am J Psychiatry; 2002 Jul; 159(7):1201-7. PubMed ID: 12091200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.